QGEN logo

QGEN Qiagen N.V.

New York Stock Exchange · Medical - Diagnostics & Research · Healthcare

$49.30
-0.33 (-0.66%)

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technolo…

Market Cap: $10.18Bwww.qiagen.com

Price

$42.30+23.50%
$32.63$35.86$39.10$42.33
May 1Aug 7

Social Signal Score

44
5d
—
30d
40
4 mentions
+0.0%
60d
42
9 mentions
+0.0%
90d
50
13 mentions
+0.0%
news: 13

Analyst Ratings

30 analysts
Holdconsensus
Strong Buy 0Buy 12Hold 18Sell 0Strong Sell 0
Avg price target$45.71-7.3%
Low $38.6Median $46.25High $52
Current Consensus

Revenue

$547.87M+49.48%
$307.71M$414.60M$521.50M$628.39M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$2.39
$2.30–$2.57
12 analysts
FY2026
$2.43+2% YoY
$2.42–$2.48
8 analysts
FY2027
$2.61+7% YoY
$2.57–$2.68
8 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Jon Pratt
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
5,400
Beta
0.56
Country
NL
Piotroski score
9 / 9 (Strong)
Altman Z-score
4.01
www.qiagen.com